• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Defibrillation therapies following sodium-glucose cotransporter 2 inhibitor treatment: A report of two cases.

作者信息

Fong Man-Cai, Feng An-Ning, Yin Wei-Hsian, Tsao Tien-Ping, Chang Hung-Yu

机构信息

Heart Center, Cheng Hsin General Hospital, Taipei, Taiwan.

Division of Cardiology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.

出版信息

HeartRhythm Case Rep. 2021 Mar 4;7(5):338-342. doi: 10.1016/j.hrcr.2021.02.009. eCollection 2021 May.

DOI:10.1016/j.hrcr.2021.02.009
PMID:34026528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8134786/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d973/8134786/d5f06e2d0123/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d973/8134786/4dd9eae6ea4f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d973/8134786/d5f06e2d0123/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d973/8134786/4dd9eae6ea4f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d973/8134786/d5f06e2d0123/gr2.jpg

相似文献

1
Defibrillation therapies following sodium-glucose cotransporter 2 inhibitor treatment: A report of two cases.钠-葡萄糖协同转运蛋白2抑制剂治疗后的除颤治疗：两例报告。
HeartRhythm Case Rep. 2021 Mar 4;7(5):338-342. doi: 10.1016/j.hrcr.2021.02.009. eCollection 2021 May.
2
Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).大多数植入式心脏复律除颤器/心脏再同步治疗除颤器患者可行无诱导或有限电击测试：多中心ASSURE研究（心律失常单次电击除颤阈值测试与易损性上限：植入式心脏复律除颤器植入的风险降低评估）结果
Circulation. 2007 May 8;115(18):2382-9. doi: 10.1161/CIRCULATIONAHA.106.663112. Epub 2007 Apr 30.
3
Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.使用带有三电极系统的植入式心脏复律除颤器进行心内膜除颤的初步临床经验。
Arch Intern Med. 1989 Oct;149(10):2333-9.
4
Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.植入式心脏复律除颤器治疗的风险分层：可穿戴式心脏除颤器的作用。
Eur Heart J. 2013 Aug;34(29):2230-42. doi: 10.1093/eurheartj/eht167. Epub 2013 May 31.
5
Implantable intravascular defibrillator: defibrillation thresholds of an intravascular cardioverter-defibrillator compared with those of a conventional ICD in humans.可植入血管内除颤器：血管内除颤复律器与传统 ICD 在人体中的除颤阈值比较。
Heart Rhythm. 2014 Feb;11(2):210-5. doi: 10.1016/j.hrthm.2013.10.035. Epub 2013 Oct 18.
6
Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial.心力衰竭患者中药物治疗、起搏与除颤比较（COMPANION）试验中心脏性猝死和恰当电击的预测因素
Circulation. 2006 Dec 19;114(25):2766-72. doi: 10.1161/CIRCULATIONAHA.106.642892. Epub 2006 Dec 11.
7
Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.胸壁单极植入式心脏复律除颤器的多中心经验。主动除颤电极导线研究者。
J Am Coll Cardiol. 1996 Aug;28(2):400-10.
8
Defibrillation testing in everyday medical practice during implantable cardioverter defibrillator implantation in France: analysis from the LEADER registry.法国植入式心脏复律除颤器植入术中日常医疗实践中的除颤测试：来自 LEADER 注册研究的分析。
Arch Cardiovasc Dis. 2013 Nov;106(11):562-9. doi: 10.1016/j.acvd.2013.07.002. Epub 2013 Nov 4.
9
Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter-defibrillators.易损性上限是经静脉植入式心脏复律除颤器的人类患者中与90%成功除颤概率相关的电击强度的良好估计指标。
J Am Coll Cardiol. 1996 Apr;27(5):1112-8. doi: 10.1016/0735-1097(95)00603-6.
10
Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter-Defibrillator Systems-A Simple Issue?皮下植入式心脏复律除颤器系统的术中除颤测试——一个简单的问题？
J Am Heart Assoc. 2016 Mar 15;5(3):e003181. doi: 10.1161/JAHA.115.003181.

本文引用的文献

1
The Effect of Shock Burden on Heart Failure and Mortality.休克负荷对心力衰竭和死亡率的影响。
CJC Open. 2019 Jun 7;1(4):161-167. doi: 10.1016/j.cjco.2019.04.003. eCollection 2019 Jul.
2
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.达格列净治疗射血分数降低的心力衰竭患者。
N Engl J Med. 2019 Nov 21;381(21):1995-2008. doi: 10.1056/NEJMoa1911303. Epub 2019 Sep 19.
3
Sacubitril/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction.
沙库巴曲缬沙坦可减少心力衰竭射血分数降低患者的室性心律失常，同时逆转左心室重构。
Clin Res Cardiol. 2019 Oct;108(10):1074-1082. doi: 10.1007/s00392-019-01440-y. Epub 2019 Feb 20.
4
Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial.恩格列净与 2 型糖尿病患者的肾功能下降：来自 EMPA-REG OUTCOME 试验的斜率分析。
J Am Soc Nephrol. 2018 Nov;29(11):2755-2769. doi: 10.1681/ASN.2018010103. Epub 2018 Oct 12.
5
Effects of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in reduced ejection fraction patients under continuous remote monitoring of implantable defibrillator devices.在植入式除颤设备连续远程监测下，比较血管紧张素-脑啡肽酶抑制与血管紧张素抑制对射血分数降低患者室性心律失常的影响。
Heart Rhythm. 2018 Mar;15(3):395-402. doi: 10.1016/j.hrthm.2017.11.012. Epub 2017 Nov 14.
6
Declining Risk of Sudden Death in Heart Failure.心力衰竭患者猝死风险降低。
N Engl J Med. 2017 Jul 6;377(1):41-51. doi: 10.1056/NEJMoa1609758.
7
Effect of the SGLT2 Inhibitor Dapagliflozin on Potassium Levels in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis.钠-葡萄糖协同转运蛋白2抑制剂达格列净对2型糖尿病患者血钾水平的影响：一项汇总分析
Diabetes Ther. 2016 Mar;7(1):125-37. doi: 10.1007/s13300-015-0150-y. Epub 2016 Jan 12.
8
Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients.LCZ696（血管紧张素受体-脑啡肽酶抑制剂）与依那普利比较，对心力衰竭患者死亡方式的影响。
Eur Heart J. 2015 Aug 7;36(30):1990-7. doi: 10.1093/eurheartj/ehv186. Epub 2015 May 28.
9
β-Blockers for the prevention of sudden cardiac death in heart failure patients: a meta-analysis of randomized controlled trials.β 受体阻滞剂预防心力衰竭患者心源性猝死：随机对照试验的荟萃分析。
BMC Cardiovasc Disord. 2013 Jul 13;13:52. doi: 10.1186/1471-2261-13-52.
10
Effects of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with left ventricular systolic dysfunction: a meta-analysis of randomized controlled trials.醛固酮受体拮抗剂对左心室收缩功能障碍患者心源性猝死风险的影响：一项随机对照试验的荟萃分析。
Circ Heart Fail. 2013 Mar;6(2):166-73. doi: 10.1161/CIRCHEARTFAILURE.112.000003. Epub 2013 Feb 12.